Concurrently, metabolic reprogramming, including shifts in glucose metabolism and lipid utilization, sustains metastatic cell growth (44), while extracellular matrix remodeling, driven by fibronectin and matrix metalloproteinases (MMPs), provides structural support for tumor invasion (45). This evidence concerns the gene FN1 and neoplasm.